Triple Therapy Versus Levofloxacin-based Therapy for Helicobacter Pylori Eradication in Mexico.

Clinical trial NCT02726269 · COMPLETED

Trial details

NCT number: NCT02726269
Sponsor: Asofarma de México S.A de C.V.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Helicobacter Pylori Gastritis

Start date: 2012-06-01
Primary completion: 2014-03-01
Enrollment: 230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.